RT @drkpavithran: Treatment with autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) is associated with improved OS for pat…

$nwbo

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

RT @JerrytheAcc: $NWBO going to be HUGE. I am excited I found this gem. This is a short term to medium term hold for easy 10x IMO. More lik…

RT @jstew34: 2 Don't take my word for it DD is key. Here is latest #JAMA with study info - note that over 70 Drs signed on to the study. Co…

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

においても、対照群の7.8ヶ月と比較して、治療群は13.2ヶ月生存しました。ワクチンで治療された患者の 13% が診断から少なくとも 5 年生存したのに対し、対照群では 5.7% であり、最長の生存者は 8 年を超えました。副作用の報告はわずか5人でした。https://t.co/dZhrgAIB9h

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

RT @GaladonGaming: $NWBO #DCVax #murcidencel #GBM #Cancer #Nature

Nature.

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @JerrytheAcc: $NWBO going to be HUGE. I am excited I found this gem. This is a short term to medium term hold for easy 10x IMO. More lik…

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

RT @drkpavithran: Treatment with autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) is associated with improved OS for pat…

$NWBO going to be HUGE. I am excited I found this gem. This is a short term to medium term hold for easy 10x IMO. More like 20x or more IMO

RT @JonksStonks: @Nature seems to think the trial was a success. But what do they know? I'll trust AF from @statnews and his Polysci degree…

RT @GaladonGaming: $NWBO #DCVax #murcidencel #GBM #Cancer #Nature

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @rago_carlo: A high honor plug from NatRev!! $NWBO

A high honor plug from NatRev!! $NWBO

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

$NWBO #DCVax #murcidencel #GBM #Cancer #Nature

@Nature seems to think the trial was a success. But what do they know? I'll trust AF from @statnews and his Polysci degree🤣 $NWBO

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @metacollectiveG: $NWBO #NWBO @statnews Who’re you going to believe?

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

@John_Hempton @justinkeister5 https://t.co/8tKGOPZBEg https://t.co/ou3DU5rk4g

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @metacollectiveG: $NWBO #NWBO @statnews Who’re you going to believe?

RT @metacollectiveG: $NWBO #NWBO @statnews Who’re you going to believe?

https://t.co/lPm1oAXH4l $nwbo #DCVax #GBM https://t.co/jPs4qJbKBo

@John_Hempton @biggercapital @statnews https://t.co/8tKGOQ09tO https://t.co/HtkWTZOJM5

@John_Hempton @biggercapital @statnews https://t.co/8tKGOQ09tO https://t.co/7n1LnYFQzi

@kgromax @BobJone59568337 @apwriter https://t.co/8tKGOQ09tO https://t.co/Ek7z7tZTPt

RT @jstew34: 2 Don't take my word for it DD is key. Here is latest #JAMA with study info - note that over 70 Drs signed on to the study. Co…

RT @albtur_mnymkrs: $nwbo #dcvax

RT @jstew34: 2 Don't take my word for it DD is key. Here is latest #JAMA with study info - note that over 70 Drs signed on to the study. Co…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @albtur_mnymkrs: $nwbo #dcvax

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

RT @NatRevClinOncol: In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for n…

$NWBO

$nwbo #dcvax

In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for newly diagnosed or recurrent glioblastoma demonstrates promising median OS durations & meaningful increases in the tails of the OS curv

RT @Ali_boy_180: . Great news sweeping through the medical community #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO https://t.co/g…

@kgromax @BobJone59568337 @apwriter https://t.co/8tKGOQ09tO https://t.co/IH9gjo4Qdc

@kgromax @BobJone59568337 @apwriter https://t.co/8tKGOPZBEg https://t.co/9yRUE923it

@kgromax @BobJone59568337 @apwriter https://t.co/8tKGOPZBEg https://t.co/uTdWzwzZot

@tiny_stix @adamfeuerstein Or this… https://t.co/iQEounorzN

Treatment with autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) is associated with improved OS for patients with newly diagnosed and recurrent GBM https://t.co/XkXFnbg7zZ https://t.co/gSE6KxTsiM

RT @Ali_boy_180: . Great news sweeping through the medical community #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO https://t.co/g…

RT @Ali_boy_180: . Great news sweeping through the medical community #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO https://t.co/g…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

2 Don't take my word for it DD is key. Here is latest #JAMA with study info - note that over 70 Drs signed on to the study. Co owns the patents for the entire platform to include manufacturing https://t.co/MHtPxAZih3 The study has been over a decade long $

RT @ilyassahinMD: 2- ~20 yıldır ilk kez, yeni teşhis edilmiş glioblastomada sistemik bir tedavi için bir faz 3 çalışmasında bu kadar önemli…

RT @ATLnsider: Thank you Dr. Musella for@posting the link to the #DCVax-L #murcidencel journal article in JAMA. Great news for $NWBO!!: htt…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

Successful phase 3 top line results for #DCVaxL, a therapeutic cancer vaccine for #Glioblastoma, in the Journal of the American Medical Association for Oncology, JAMA Oncol, published online November 17, 2022 $NWBO #DrLindaLiau #Murcidencel https://t.co/

@JonathanWosen @adamfeuerstein @statnews Is anyone @statnews doing any due diligence by themselves? Seems people working at STAT just blindly believe whatever and by whomever is written on there is the truth. And/or are told to do so. Stop being a fool too

RT @NeuroscienceNew: “Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients Wi…

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma. A Phase 3 Prospective Externally Controlled Cohort Trial https://t.co/aDQHIkIyIP https://t.c

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

. Great news sweeping through the medical community #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO https://t.co/gSvGnjja9O

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @albtur_mnymkrs: Doctors love #dcvax $nwbo

RT @albtur_mnymkrs: Trust the doctors. $nwbo #dcvax

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @ProvSwedCancRes: Dr. Charles Cobbs of SNI @ProvSwedCancRes @ProvSwedish co-authors a study on #immunotherapy #vaccine studies for #glio…

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

@statnews https://t.co/8tKGOPZBEg https://t.co/XoJCB31m9U

@statnews https://t.co/8tKGOQ09tO https://t.co/SQIz7hsYPT

@statnews https://t.co/8tKGOPZBEg

@MarcJacksonLA @statnews https://t.co/8tKGOPZBEg https://t.co/rxHP7QzQ22

RT @albtur_mnymkrs: Doctors love #dcvax $nwbo

RT @Dave46217976: $NWBO #DCVAX

RT @Dave46217976: $NWBO #DCVAX

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

Dr. Charles Cobbs of SNI @ProvSwedCancRes @ProvSwedish co-authors a study on #immunotherapy #vaccine studies for #glioblastoma resulting in improved #survival https://t.co/K9bRItHxAk

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/LSraL9xi47 #braincancer

RT @SeekingTruth4us: @backtolife_2023 https://t.co/wZyDCZZ5FX Phase 3 median survival was only 19.3 months vs 16.5 due to low response rate…

RT @SeekingTruth4us: @backtolife_2023 https://t.co/wZyDCZZ5FX Phase 3 median survival was only 19.3 months vs 16.5 due to low response rate…

@backtolife_2023 https://t.co/wZyDCZZ5FX Phase 3 median survival was only 19.3 months vs 16.5 due to low response rates, Not even FDA approved-yet they charge 6 figures regardless while repurposed-natural agents https://t.co/r0xkEOFvXS suppressed🤔👇https://